Exploratory Trial Evaluating Cosentyx (Secukinumab) for Patients With Moderate-to-Severe Hidradenitis Suppurativa
Clinical trial NCT03099980 · COMPLETED
Trial details
- NCT number
- NCT03099980
- Sponsor
- Tufts Medical Center
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-11
- Primary completion
- 2018-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.